Drug Interaction Study of Henagliflozin and Simvastatin in Healthy Volunteers

Trial Profile

Drug Interaction Study of Henagliflozin and Simvastatin in Healthy Volunteers

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Nov 2017

At a glance

  • Drugs Henagliflozin (Primary) ; Simvastatin
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Jiangsu Hengrui Medicine Co.
  • Most Recent Events

    • 07 Nov 2017 Planned End Date changed from 27 Nov 2017 to 8 Dec 2017.
    • 07 Nov 2017 Planned primary completion date changed from 20 Nov 2017 to 4 Dec 2017.
    • 07 Nov 2017 Planned initiation date changed from 1 Oct 2017 to 24 Nov 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top